Skip to main content
SpringerLink
Log in

Schmerztherapie in der Palliativmedizin

  • Chapter
Palliativmedizin

Zusammenfassung

Schmerzen sind ein sehr komplexes Geschehen: Neben den biologischen Ursachen bestehen psychische, soziale und spirituelle Einflüsse auf Schmerzempfindung und Schmerzverarbeitung (total-pain-Konzept). Bei entsprechend differenzierter Wahrnehmung all dieser Bereiche kann eine gezielte, multiprofessionelle Behandlung erfolgen. Die medikamentöse Schmerztherapie hat sich vielfältig durch neue Substanzen und Verabreichungsformen entwickelt. Deren Einsatz erfordert gute Kenntnisse. In manchen Situationen sind lokale invasive Maßnahmen zielführender als nur systemische Therapien. Das weite Feld der nichtmedikamentösen Schmerzbehandlung setzt eine gewisse Rezeptivität der Leidenden und eine Authentizität der Behandler voraus. Dann stehen viele Zugänge offen: physiotherapeutisch, psychotherapeutisch und verschiedene Entspannungsverfahren.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

Literatur zu Abschn. 4.1

  • American Geriatrics Society Panel (2009) Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 57(8):1331–1346

    Google Scholar 

  • Basmacioglu B, Aydinli I et al (2009) Effect of intravenous administration of paracetamol on morphine consumption in cancer pain control. Support Care Cancer 17(12):1475–1481

    Google Scholar 

  • Bennett MI, Laird B et al (2013) Pregabalin for the management of neuropathic pain in adults with cancer: a systematic review of the literature. Pain Med 14:1681

    Google Scholar 

  • Bell RF, Eccleston C et al (2012) Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 11:CD003351

    Google Scholar 

  • Beubler E (2012) Kompendium der medikamentösen Schmerztherapie-Wirkungen, Nebenwirkungen und Kombinationsmöglichkeiten, 5. Aufl., Springer, Wien S. 23–25

    Google Scholar 

  • Bingel U, Schedlowski M (2015) Die Bedeutung von Placebomechansimen in der Schmerztherapie. In: Kress HG (Hrsg) Aktuelle Schmerzmedizin, economed Medizin, Hüthig Jehle Rehm, Landsberg/Lech, S. 9–12

    Google Scholar 

  • Breivik H, Cherny N et al (2009) Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 20(8):1420–1433

    Google Scholar 

  • Branford R, Wighton E et al (2010) Principles of drug therapy: focus on opioids. In: Hanks G, Cherni NI, Christakis NA, Fallon M, Kassa S, Portenoy RK (Hrsg) Oxford textbook of palliative medicine, 4.Aufl. Oxford Univerity Press, Oxford, S. 493–505

    Google Scholar 

  • Brune K, Hinz B (2001) Nichtopioidanalgetika (antipyretische Analgetika und andere). In: Zenz M, Jurna I (Hrsg) Lehrbuch der Schmerztherapie, 2.Aufl. Wissenschatliche Verlagsgesellschaft, Stuttgart, S. 233–253

    Google Scholar 

  • Cherny NI, Cleary J et al (2013) The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: introduction and methodology. Ann Oncol 24(11):7–13

    Google Scholar 

  • Coxib and traditional NSAID Trialists’ (CNT) Collaboration (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382(9894):769–779

    Google Scholar 

  • Dahan A, Yassen A, Romberg R et al (2006) Buprenorphine induces ceiling in respiratory depression but not in analgesia Dahan. Br J Anaesthesia 96(5):627–632

    Google Scholar 

  • Dale O, Moksnes K, Kaasa S (2011) European Palliative Care Research Collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review. Palliat Med 25(5):494–503

    Google Scholar 

  • Davies AN, Dickman A et al (2009) Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 13(4):331–338

    Google Scholar 

  • Derry S , Moore RA et al (2012) Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev 2012 Sept 12;(9):CD007400

    Google Scholar 

  • Eisenberg E, Marinangeli F et al (2005) Time to modify the WHO analgesic leader? Pain Clin Update 13(5):1–4

    Google Scholar 

  • Fallon MT (2013) Neuropathic pain in cancer. Br J Anesthesia 111(1):105–111

    Google Scholar 

  • Farquhar-Smith WP (2009) Do cannabinoids have a role in cancer pain management? Curr Opin Support Palliat Care 3(1):7–13

    Google Scholar 

  • FDA Public Health Advisory (2012). Risk of burns during MRI scans from transdermal drug patches with metallic backings. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm111313.htm

  • Fine PG, Portenoy RK (2009) Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation. Establishing »best practices« for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage 38(3):418–425

    Google Scholar 

  • Finnerup NB, Sindrup SH et al (2010) The evidence for pharmacological treatment of neuropathic pain. Pain 150: 573–581

    Google Scholar 

  • Finnerup NB, Attal N et al (2015) Pharmacotherapy of neuropathic pain in adults: a systemic review and metaanalysis. The Lancet neurology 14(2):162–173

    Google Scholar 

  • Finniss DG, Benedetti F (2005) Mechanisms oft he placebo response and their impact on clinical trials and clinical practice. Pain 114(1-2):3–6

    Google Scholar 

  • Franceschi M, Scarcelli C et al (2008) Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 31(6):545–556

    Google Scholar 

  • Frohlich M, Gianotti A et al (2002) Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg 93:647–648

    Google Scholar 

  • Indelicato RA, Portenoy RK (2002) Opioid rotation in the management of refractory cancer pain. J Cin Oncol 20:348–352

    Google Scholar 

  • Klaschik E, Clemens KE (2005) Opioide in der Tumorschmerztherapie – Wirksamkeit und Nebenwirkungen. Schmerz 19:395–403

    Google Scholar 

  • Klinger R, Schedlowski M et al(2010) Placebo Effekt in Schmerztherapie und -forschung. In: Kröner-Herwig B, Frettlöh J, Klinger R, Nilges P (Hrsg) Schmerzpsychotherapie, Springer, Berlin Heidelberg, S. 161–163

    Google Scholar 

  • Kraft B, Kress HG (2008) Cannabinoide in der Schmerz und Palliativmedizin. In: Kress HG (Hrsg) Aktuelle Schmerzmedizin, economed Medizin. Hüthig Jehle Rehm, Landsberg/Lech, S. 9–12

    Google Scholar 

  • Lamberts M, Lip GYH et al (2014) Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: A nationwide cohort study. Ann Intern Med 161:690–698

    Google Scholar 

  • Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung (2015) Evidenztabellen 1.0, AWMF-Registernummer: 128 / 001OL, http://leitlinienprogramm-onkologie.de/Palliativmedizin.80.0.html

  • Likar R, Sittl R (2002) Praxis der transdermlen Schmerztherapie. UNI-MED, Bremen

    Google Scholar 

  • Loke YK, Trivedi AN et al (2008) Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 27:31–40

    Google Scholar 

  • Lux EA, Heine J (2011) Home care treatment of cancer pain patients with patient-controlled analgesia (PCA) Schmerz 25(6):663–667

    Google Scholar 

  • Maltoni M, Scarpi E et al (2005) A validation study of the WHO analgesic ladder: a two-step vs three-step strategy. Support Care Cancer 13(11):888–894

    Google Scholar 

  • Marinangeli F , Ciccozzi A et al (2004) Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage 27(5):409–416

    Google Scholar 

  • Meier T, Wasner G et al (2003) Efficacy of lidocaine patch 5 % in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 106(1-2):151–158

    Google Scholar 

  • Mercadante S, Nabal M et al (2012) European Palliative Care Research Collaborative (EPCRC); European Association for Palliative Care (EAPC) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC, Lancet Oncol 13(2):e58–68

    Google Scholar 

  • Mercadante S, Porzio G et al (2012) Tapentadol in cancer pain management: a prospective open-label study. Pain 28(11):1775–1779

    Google Scholar 

  • Mishra S, Bhatnagar S et al (2012) A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care 29:177–182

    Google Scholar 

  • Mou J, Paillard F et al (2013) Efficacy of Qutenza® (capsaicin) 8 % patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database. 154(9):1632–1639

    Google Scholar 

  • Nabal M, Librada S et al (2011) The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature. Palliat Med 26(4):305–312

    Google Scholar 

  • Nauck F, Radbruch L (2011) Systemische medikamentöse Schmerztherapie In: Aulbert E, Nauck F, Radbruch L (Hrsg) Lehrbuch der Palliativmedizin, 3. Auflage. Schattauer, Stuttgart, S. 175–205

    Google Scholar 

  • Nauck F, Klaschik E (2002) Schmerztherapie. Kompendium für Ausbildung und Praxis. Wissenschaftliche Verlagsgesellschaft Stuttgart

    Google Scholar 

  • Okamoto Y, Tsuneto S et al (2013) Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer? Am J Hosp Palliat Care 30:450

    Google Scholar 

  • Okie S (2010) A Flood of Opioids, a Rising Tide of Deaths. N Engl J Med 363(21):1981–1985

    Google Scholar 

  • Pasero C (2007) IV opioid range orders for acute pain management. AJN 107(2):52–59

    Google Scholar 

  • Paulsen AN, Kaasa S et al (2013) Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review. J Pain Symptom Manage 46:96

    Google Scholar 

  • Portenoy RK, Ahmed E et al (2015) Cancer pain management: Adjuvant analgesics (coanalgesics). UpToDate

    Google Scholar 

  • Portenoy RK, Ahmed E et al (2014) Cancer pain management: Use of acetaminophin and nonsteroidal antiinflammatory drugs. UptoDate

    Google Scholar 

  • Portenoy RK, Hagen NA (1990) Breakthrough pain: definition, prevalence and characteristics. Pain 41(3):273–281

    Google Scholar 

  • Portenoy RK, Ahmet E (2013) Adjuvant Analgesics in Management of Cancer-Related Neuropathic Pain, Encyclopedia of Pain, pp 71–75

    Google Scholar 

  • Radbruch L, Sabatowski R et al (2001) Transdermal fentanyl fort he management of cancer pain: a survey of 1005 patients. Palliat Med 15:309–321

    Google Scholar 

  • Rezende RM, França DS et al ( 2008) Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain. Br J Pharmacol 153(4):760–768

    Google Scholar 

  • Rogosch T, Sinning C et al (2012) Novel bioactive metabolites of dipyrone (metamizol). Bioorg Med Chem 20(1):101–107

    Google Scholar 

  • Saunders CM (1978) The Management of terminal malignant disease,. Edward Arnold, London

    Google Scholar 

  • Schick V, Schulz HJ (2010) Nichtsteroidale Antirheumatika und Gastrointestinaltrakt Gastroenterologie 5:461–472

    Google Scholar 

  • Schubert I, Ihle P et al (2013) Zunahme der Opioidverordnungen in Deutschland zwischen 2000 und 2010: Eine Studie auf der Basis von Krankenkassendaten, Dtsch Arztebl Int 110(4):45–51

    Google Scholar 

  • Smith HS, Peppin JF (2014) Toward a systematic approach to opioid rotation. J Pain Res 7:589–608

    Google Scholar 

  • Stockler M, Vardy J et al (2004) Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol 22(16):3389–3394

    Google Scholar 

  • Svendsen KB, Andersen S et al (2005) Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain 9(2):195–206

    Google Scholar 

  • Tassinari D, Sartori S et al (2008) Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature. J Palliat Med 11(3):492–501

    Google Scholar 

  • Tremont-Lukats IW, Challapalli V et al (2005) Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 101:1738

    Google Scholar 

  • Twycross R (1999) Opioids. In: Wall PD, Melzack R (Hrsg) Textbook of pain, 4. Aufl. Churchill Livingston, Edinburgh London, S. 1187–1214

    Google Scholar 

  • Vaile JH, Davis P (1998) Topical NSAIDs for musculoskeletal conditions. Drugs 56(5):793–799

    Google Scholar 

  • Van den Beuken-vanEverdingen MHJ, de Rijke JM et al (2007) Prevalence of pain in patients with cancer:a systemic review of the past 40 years. Ann Oncology 18(9):1437–1449

    Google Scholar 

  • Vargas-Schaffer G (2010) Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician 56(6):514–517

    Google Scholar 

  • Weber LM, Ghafoor VL et al (2008) Implementation of standard order sets for patient-controlled analgesia. Am J Health Syst Pharm 65(12):1184–1191

    Google Scholar 

  • WHO (1996) Cancer pain relief, with a guide to opioid availability. World Health Organization, Geneva

    Google Scholar 

  • Wong MH, Stockler MR et al (2012) Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev 2:CD003474

    Google Scholar 

  • Zech DF, Grond S et al (1995) Validation of World Health Organization guidelines for cancer pain relief: a 10 year prospective study. Pain 63(1):65–76

    Google Scholar 

  • Zeppetella G, Davies AN (2013) Opioids for the management of breakthrough pain in cancer patients. Cochrane Database Syst Rev 10:CD004311

    Google Scholar 

Literatur zu Abschn. 4.2

  • Amesbury B, O’Riordan J (1999) The use of interpleural analgesia using bupivacaine for pain relief in advanced cancer. Palliat Med 13(2):153–158

    Google Scholar 

  • Baker L, Lee M, Regnard C et al (2004) Evolving spinal alagesia practice in palliative Care. Palliat Med 18:507–515

    Google Scholar 

  • Ballantyne JC et al (1996) Comparative efficacy of epidural, subarachnoid and Intracerebro-ventricular opioids in patients with pain due to cancer. Regional Anesthesia 21(6):542–556

    Google Scholar 

  • Cleary JF (2000) Cancer pain management. Cancer Control 7(2):120–131

    Google Scholar 

  • Deer TR, Prager J, Levy R et al (2012) Polyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel; Neuromodulation

    Google Scholar 

  • Eisenberg E, Carr DB, Chalmers TC (1995) Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis Anesth Anal. 1995 Feb;80(2):290-5

    Google Scholar 

  • Lema MJ (2001) Invasive analgesia techniques for advanced cancer pain. Surg Oncol Clin N Am 10(1):127–136

    Google Scholar 

  • Lynch J, Zech D, Grond S (1992) The role of intrathecal neurolysis in the treatment of cancer-related perianal and perineal pain. Palliat Med 6(2):140–145

    Google Scholar 

  • Mummenthaler M et al (Hrsg) (1990)Treatment of Chronic Pain: Possibilities, Limitations and Long-term Follow-Up. Harwood, London

    Google Scholar 

  • Nagels W, Pease N, Bekkering G (2013) Celiac Plexus Neurolysis for Abdominal Cancer Pain: A systematic Review. Pain Medicine 14:1140–1163

    Google Scholar 

  • Nitescu P, Applegren L, Lindler L (1990) Epidural versus intrathecal morphine bupivacaine: Assessment of consecutive treatments in advanced cancer pain. J Pain Syndrom Manag 5:18–26

    Google Scholar 

  • Plancarte R, de Leon-Casasola OA, El-Helaly M et al (1997) Neurolytic superior hypogastric plexus block for chronic pain associated with cancer. Reg Anaesth 22:562–568

    Google Scholar 

  • Raphael J, Hester J, Ahmedzai S et al (2010) Cancer Pain: Part 2: Physical, Interventional and Complimentary Therapies, Management in the Community; Acute , Treatment-Related and Complex Cancer Pain; A Perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Medicine 11:872–896

    Google Scholar 

  • Shankar H, Khatri V, Eastwood D (2010) Retrospektive Comparison of Ultrasound and Fluoroscopie Image Guidance for Intercostal Steroid Injections. Pain Practice 10(4):312–317

    Google Scholar 

  • Smith TJ, Staats PS, Deer T et al (2002) Implantable drug delivery systems study group. Randomised clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain; impact on pain, drug related toxicity and survival. J Clin Oncol 20:4040–4049

    Google Scholar 

  • Vissers KCP, van den Brand MWM, Jacobs J et al (2013) Palliative Medicine Update: A Multidisciplinary Approach. Pain Practice 13(7):576–588

    Google Scholar 

  • Williams JE, Louw G, Towlerton G (2000) Intrathecal pumps for giving opioids in chronic pain: A systematic review. Health Technol Assess 4(32):1–65

    Google Scholar 

  • Wong FCS, Lee TW, Yuen KK et al (2007) Intercostal nerve blockade for cancer pain: Effectiveness and selection of patients. Hong Kong Med J 13:266–270

    Google Scholar 

  • Yamamuro M, Kusaka K, Kato M, Takahashi M (2000) Celiac Plexus Block in Cancer Pain Management. Tohoku J Exp Med 192:1–18

    Google Scholar 

  • Yan BM, Myers RP (2007) Neurolytic celiac plexus block for pain control in unresectable pancreatic. Cancer Am J Gastroenterol 102(2):430–438

    Google Scholar 

Literatur zu Abschn. 4.3

  • AWMF (2015) Leitlinienprogramm Onkologie/S 3-Leitlinie Palliativmedizin. AWMF-Registernummer: 128/001OL, S. 60

    Google Scholar 

  • Basler HD, Kröner-Herwig B et al (2003) Pychologische Schmerztherapie 5. Aufl. Springer, Heidelberg

    Google Scholar 

  • Bernatzky G, Presch M, Anderson M, Panksepp J ( 2011) Emotional foundations of music as a non-pharmacological pain management tool in modern medicine. Neuroscience and Biobehavioral Reviews 35:1889-99

    Google Scholar 

  • Bernatzky G, Hesse HP ( 2012) Musik in der Palliativmedizin. In: Bernatzky G., Sittl R., Likar R. (Hrsg.): Schmerzbehandlung in der Palliativmedizin 3., überarb Aufl Springer Wien S. 229–234

    Google Scholar 

  • Bernatzky G, Wendtner F, Flock T (2014) Entspannung bei Stress 2, Wohlfühl-CD zum Entschleunigen, Entspannen und Regenerieren. Musik mit Entspannungsanleitung; Audio CD © Spield.: 51:16 min, Verlag clara lumina

    Google Scholar 

  • Bernstein DA, Borkovec TD (2000) Entspannungstraining. Handbuch der progressiven Muskelentspannung nach Jacobson Klett-Cotta, Stuttgart

    Google Scholar 

  • Erickson MH (1959) Hypnosis in painful terminal illness. Am J Clin Hypn;1:117–21

    Google Scholar 

  • Gatterer G (2009) Progressive Muskelentspannung nach Jacobson. In: Likar R, Bernatzky G, Märkert D, Ilias W (Hrsg) Schmerztherapie in der Pflege, Springer Wien

    Google Scholar 

  • Jensen KB, Petrovic P, Kerr C et al ( 2014) Sharing pain relief: Neural correlates od physicians during treatment of patients. Mol Psychiatry19:392–398

    Google Scholar 

  • Kaiser-Rekkas A (2009) Hypnosetherapie beim Schmerz. In: Likar R, Bernatzky G. Schmerztherapie in der Pflege. Springer Wien NewYork; 241–247

    Google Scholar 

  • Kant I (1998) Kritik der reinen Vernunft. Meiner Verlag, Hamburg 1998,

    Google Scholar 

  • Nieland P (2009) Physiotherapie in der Palliativmedizin. Z Palliativmed 10:85–101

    Google Scholar 

  • Petrovic P, Kalso E, Petersson KM, Ingvar M ( 2002) Placebo and Opioid Analgesia – Imaging a Shared Neuronal Network. Science 295:1737–1740

    Google Scholar 

  • Petzold H (2004)Integrative Therapie. Modelle, Theorien und Methoden einer schulenübergreifenden Psychotherapie, 3 Bände, 2. Auflage, Junfermann, Paderborn

    Google Scholar 

  • Revenstorf D (2006) Expertise zur Beurteilung der wissenschaftlichen Evidenz des Psychotherapieverfahrens Hypnotherapie entsprechend den Kriterien des Wissenschaftlichen Beirats Psychotherapie. Hypnose ZHH Band 1 und 2

    Google Scholar 

  • Schultz JH (1932) Das autogene Training (konzentrative Selbstentspannung). Versuch einer klinisch-praktischen Darstellung. Thieme, Leipzig

    Google Scholar 

  • Schulze W (2013) Hypnose und Hypnotherapie in der Palliativmedizin – Symptombehandlung und spirituelle Begleitung. Z. Palliativmed 14:59–72

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Landeskrankenhaus Hohenems, Bahnhofstraße 31, 6845, Hohenems, Österreich

    Dr. Otto Gehmacher (Leiter der Palliativstation)

  2. Vorstand der Abteilung für Anästhesie und Intensivmedizin, Klinikum Klagenfurt am Wörthersee, Feschnigstraße 11, 9020, Klagenfurt, Österreich

    Prim. Univ. Prof. Dr. Rudolf Likar MSc

  3. Dr.-Mack-Straße 37a, 90762, Fürth, Deutschland

    Dr. Reinhard Sittl

  4. Dr.-Summer-Straße 3, 6830, Rankweil, Österreich

    Univ. Prof. Dr. Gebhard Mathis

Authors
  1. Dr. Otto Gehmacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prim. Univ. Prof. Dr. Rudolf Likar MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. Reinhard Sittl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Univ. Prof. Dr. Gebhard Mathis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Fana, Norway

    Stein Husebø

  2. Rankweil, Austria

    Gebhard Mathis

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Gehmacher, O., Likar, R., Sittl, R., Mathis, G. (2017). Schmerztherapie in der Palliativmedizin. In: Husebø, S., Mathis, G. (eds) Palliativmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49039-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-49039-6_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-49038-9

  • Online ISBN: 978-3-662-49039-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation